SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 9, 1997
Commission file number: 0-21464
PruTech Research and Development Partnership II
- -----------------------------------------------------------------------------
(Exact name of Registrant as specified in its charter)
California 13-3268435
- -----------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employer
Identification No.) incorporation or organization)
440 Mission Court, Suite 250, Fremont, California 94539
- -----------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (510) 656-1855
N/A
- -----------------------------------------------------------------------------
Former name, former address and former fiscal year, if changed since last
report.
<PAGE>
Item 2 - Aquisition or Disposition of Assets
During the third quarter and through October 9, 1997, the
Registrant sold its remaining 136,000 shares of Ecogen Inc. common stock for
approximately $441,000. The sale proceeds resulted in a decrease of
approximately $35,000 in the estimated net liquidation value of the
Registrant's assets and liabilities from the June 30, 1997 value for financial
reporting purposes.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PruTech Research and Development Partnership II
By: R&D Funding Corp
A Delaware corporation, General Partner
By: /s/ Steven Carlino Date: October 29, 1997
- ---------------------------------------------
Steven Carlino
Vice President
Chief Accounting Officer for the Registrant
